Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-14-001691
Filing Date
2014-02-14
Accepted
2014-02-14 13:54:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 d1452737_13g-a.htm SC 13G/A 194954
  Complete submission text file 0000919574-14-001691.txt   196636
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39444 | Film No.: 14614335
SIC: 2834 Pharmaceutical Preparations

Mailing Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017 212-808-2463
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A